Optical coherence tomography angiography is a non-invasive imaging technique that now allows for simultaneous in vivo imaging of the morphology as well as the vasculature in the eye. In this review, we provide an update on the existing clinical applications of optical coherence tomography angiography technology from the anterior to posterior segment of the eye. We also discuss the limitations of optical coherence tomography angiography technology, as well as the caveats to the interpretation of images. As current optical coherence tomography angiography systems are optimized for the retina, most studies have focused on interpreting images from conditions such as age related macular degeneration and retinal vascular diseases. However, the interpretation of these optical coherence tomography angiography images should be taken in consideration with other multimodal imaging to overcome the limitations of each technique. In addition, there are a growing variety of clinical applications for optical coherence tomography angiography imaging in optic nerve head evaluation for glaucoma and optic neuropathies. Further developments in anterior optical coherence tomography angiography have now allowed for evaluation of anterior segment pathology such as glaucoma, ocular surface diseases, corneal vascularisation, and abnormal iris vasculature. Future developments in software could allow for improved segmentation and image resolution with automated measurements and analysis.
Introduction
Today, classical optical coherence tomography (OCT) is able to provide structural information on ocular tissues with unprecedented resolution. Typically, structural OCT scans produce poor delineation of blood vessels as light is scattered by moving erythrocytes [1] . This scatter also leads to a shadow effect behind or beneath the blood vessels and thus, images of deeper layers underneath larger vessels are typically lost [2] . However, with increased sensitivity and speed of OCT systems, it is now possible to delineate blood vessels using OCT by using decorrelation between consecutive scans. The basis of OCT angiography (OCTA) is essentially comparing consecutive B-scans, which is now possible with B-scan rates of several hundred hertz (Hz) -optimal for detecting flow in the microvasculature of the eye. This can either be done based on comparing changes in intensity, phase speckle contrast or a variation of the full complex OCT signal [3] .
Thus, OCTA is a rapidly emerging, non-invasive imaging modality that provides three-dimensional delineation of vascular structures within the eye, without the need to intravenously administer fluorescent dyes [4, 5] . The other potential advantages include a fast acquisition time that allows for repeated scans, higher resolution of capillaries without obscuration by leakage, and the ability to perform depthresolved analysis, in which the flow within a specific axial location of the retina or choroid can be analyzed [6] . However, its current limitations include a restricted field of view, and lack of information on flow or filling speed, without the ability to demonstrate exudation or leakage. In the deeper layers, vessels from the superficial vasculature can appear as projection artifacts caused by multiple scattering [7] . Another major issue is related to motion artifacts, which may be corrected using a motion tracking system or on postprocessing using different approaches, but it still constitutes a problem in clinical applications of this technology.
Currently, commercially available OCTA systems use various proprietary algorithms such as full or split-spectrum amplitude-decorrelation angiography (FSADA or SSADA), optical microangiography (OMAG) and OCT angiography ratio analysis (OCTARA) [8] . In addition, many differences exist between OCTA platforms such as scanning speed, acquisition time, processing time, automated segmentation and options of varying the scan area size. Generally, an optimal balance between sampling density, B-scan repetition and field of view needs to be found. Oversampling (repeated scans within one spot size of the laser beam) increases quality but also increases risk of bulk motion artifacts. Typical measurement times are currently between 3 and 6 s, a period during which most subjects are able to fixate a target. Other devices, with an eye-tracking system, have longer acquisition times allowing for accurate follow-up comparison. The area that can be scanned within this time frame depends on the A-scan rate of the system. With commercially available OCT machines (up to 70 kHz for spectrometer-based systems and up to 100 kHz for swept-source based systems), areas of either 3 × 3 mm, 6 × 6 mm, and 9 × 9 mm are typically scanned with decreasing oversampling rates.
The purpose of this review is to summarize the current clinical applications of OCTA from the posterior segment to the optic nerve head and the anterior segment. In this concise review, the main area of focus would be a summary of clinical applications, instead of the technical aspects, comparison to other imaging techniques or basic interpretation of images, which has already been covered by previous review articles [9, 10] . In this review we also include potential future clinical applications and developments in the OCTA technology arena.
Optical coherence tomography angiography for the posterior segment
To date, most OCTA technology and algorithms have been optimized for the posterior segment and a wide range of potential clinical applications have emerged [4] . Interpretation of posterior segment OCTA images, however, involves a significant learning curve and is not always straightforward. OCTA systems generate both crosssectional Bflow^images (B-scans) and en face sections (Figs. 1, 2, and 3, Supplementary Fig. 2-4 ). For accurate interpretation, each of these should be viewed in a dynamic fashion and closely correlated. Manual manipulation of the images is often required to optimize the vascular details of interest. Awareness of potential sources of artifacts due to suboptimal image acquisition, patient factors, poor segmentation, projection (Fig. 2, supplementary Fig. 4 ) and unmasking artifacts (Fig. 2) is also required to ensure optimal OCTA interpretation [11] [12] [13] .
OCTA imaging is particularly useful in retinal vascular diseases, such as diabetic retinopathy and retinal venous occlusion, where it allows delineation and quantification of the foveal avascular zone (FAZ) [14, 15] , (Fig. 1 ) detection of macular ischaemia, and some assessment of midperipheral retinal non-perfusion ( Fig. 1, supplementary  Fig. 1 ) [16] . Interestingly, previous studies have suggested that increases in the FAZ area may precede the development of clinically evident diabetic retinopathy -this has significant potential implications for the screening of this condition [17, 18] . Posterior segment OCTA also allows improved visualization of retinal vascular abnormalities such as micro-and macroaneurysms [14, 19] , telangiectasia [20] , vascular loops [21] , and venous beading ( Fig. 1 , supplementary Fig. 1 ) [22] . Through the correlation of crosssectional and en face OCTA images, it is now possible to easily distinguish between pre-retinal neovascularisation and intraretinal microvascular abnormalities (IRMAs) or collateral vessels ( Fig. 1 ) [23] . OCTA may also provide new insights into diseases such as macular telangiectasia (MacTel) type 2 (supplementary Fig. 2 ). Recent studies suggest that the characteristic stellate arrangement of Btelangiectatic^vessels seen in the temporal macula may be caused by contraction of the surrounding tissue (supplementary Fig. 2 ) [24] . These findings cannot be elucidated using either conventional angiography or structural OCT. OCTA also provides improved visualization of the subretinal neovascularisation that sometimes develops in this condition [25] .
OCTA imaging has huge potential for the diagnosis of choroidal neovascularization (CNV) in patients with agerelated macular degeneration (AMD) (Fig. 2) [26] . In many cases, direct visualization of the choroidal neovascular membrane is possible, whether it be in the subretinal (type 2) or sub-RPE space (type 1), and patients may be spared the need for invasive angiography (Fig. 2) [27, 28] . Retinal angiomatous proliferation (RAP) lesions, also known as type 3 neovascularisation, may also be seen on OCTA as a small, high-flow, tuft of abnormal vessels on en face OCTA images (Fig. 2) [29] . These lesions are often subtle and close correlation between cross-sectional images and superimposed flow is recommended (Fig. 2) . The role of OCTA in polypoidal choroidal vasculopathy (PCV) is less well defined (supplementary Fig. 3 ). OCTA is readily capable of highlighting the branching vascular networks (BVNs) in this condition but is not as reliable as ICGA in the detection of polyps (supplementary Fig. 3 ) [30] [31] [32] . On cross-sectional OCTA, polyps show patchy flow signals with the lumen being largely devoid of flow (supplementary Fig. 3 ) [32] . OCTA may be of particular use in the diagnosis of CNV that is not related to AMD (e.g., myopic CNV) [33] , and in situations where accurate interpretation of conventional angiography is likely to be challenging (e.g., in CNV secondary to central serous chorioretinopathy (CSCR) [34] , or CNV secondary to inflammatory conditions such as multifocal choroiditis (supplementary Fig. 4 ) [35] . OCTA has also been suggested for the monitoring of patients with known CNV, with attempts to characterize CNV morphology in clinically active versus inactive disease (Fig. 3) . In this regard, active lesions have been described with a Bmedusa^or Bsea-fan^appearance, while chronic, inactive lesions have been described as having a Bdead tree^aspect (Fig. 3) [36] . In real world clinical practice, use of OCTA in this manner is challenging and further effort will be required to validate such an approach.
Optical coherence tomography angiography for the optic nerve head
As primary open angle glaucoma (POAG) is an optic neuropathy with a possible vascular component in its multifactorial etiology [37] , OCTA imaging suggests attenuation of the vasculature associated with the optic nerve head microvasculature [38, 39] . Moreover, combining conventional OCT with OCTA may allow for the simultaneous evaluation of the retinal nerve fiber layer (RNFL) structure and optic disc sector perfusion, which may correlate with glaucoma severity and the associated visual field loss [40] . Further studies are required to study the temporal association between vascular and structural changes of the retinal ganglion cells and the vascular supply captured by OCTA imaging. However, effects on visual function such as reduced visual field sensitivity may only appear after subsequent damage occurs. Thus, there is a potential for OCTA to detect pre-perimetric POAG even in the presence of RNFL thinning [41] . OCTA may also be helpful for exploring vascular changes in secondary glaucomatous optic neuropathies [42] .
The role of OCTA in detecting optic neuropathies directly associated with vascular pathology, should in theory, be even more promising. Studies have demonstrated delineation of changes in peripapillary microvasculature in acute non-arteritic anterior ischemic optic neuropathy (NAION), and after resolution of the optic disc swelling [43] . One of the proposed mechanisms underlying NAION is a transient hypoperfusion in the deeper capillary beds of the optic nerve head. Vascular congestion is also seen in OCTA images from tortuous capillaries within or surrounding the optic disc in NAION [44] . A potential clinical application of OCTA in NAION is monitoring recovery, as an early OCTA study revealed partial recovery of peripapillary vascular flow was associated with a modest improvement in visual function [43] . Moreover, OCTA may also have the ability to evaluate progression of NAION from a preclinical to a full clinical presentation [43] . On the other hand, disc-swelling secondary to conditions such as idiopathic intracranial hypertension may show vessel tortuosity without associated vascular dropout and relatively preserved peripapillary microvasculature in the early stage [44] . However, current limitations of OCTA technology include the reduction of the flow density at different layers in NAION is confounded by imaging artifacts from edema or the presence of blood (Fig. 4) . Nonetheless, further studies on this application of OCTA in optic neuropathies with a vascular etiology could have great implications on clinical practice. Another role of OCTA in evaluating the optic nerve head is in optic neuritis, where previous episodes of inflammation were associated with reduction in peripapillary vascular flow index [45, 46] . The OCTA may also demonstrate some residual microvascular abnormalities of the optic nerve head even after treatment and recovery of visual function [46] .
Optical coherence tomography angiography for the anterior segment
Currently, angiography such as ICGA for the anterior segment is not commonly performed in a clinic due to the potential risk of adverse reactions to the dye [47, 48] . The main advantage of anterior OCTA is that images are rapidly acquired using a non-contact technique [48] . However, it is important to note that current commercial OCTA systems are not specifically designed for the anterior segment but may be adapted to assess the cornea, iris or scleral vessels Right column: Non-neovascular AMD with geographic atrophy (GA) atrophy seen on cross-sectional OCTA with boundaries marked by a hypertransmission signal in the choroid (bottom-green dotted lines) that contains a flow signal, which resulted in a corresponding unmasking artifact seen on en face OCTA in the area of GA (top-green dotted lines). No flow signal was seen within the retina layers in this case [48] . While the SSADA system has been most commonly described for the anterior segment, other spectral domain and swept source OCTA systems have also been successfully adapted for the anterior segment as prototypes in development [49, 50] .
Similar to the OCTA for the posterior segment, one must recognize the limitations and caveats to interpretation of anterior OCTA scans. For example, the OCTA is unable to demonstrate vessel leakage, and has a limited field of view compared to the FA and ICGA [51] . However, leakage of dye tends to hinder images of microvasculature in the cornea, while OCTA has been found to be comparable to ICGA for visualization of corneal vascularisation [52] . It is also important to recognize image artifacts from saccadic eye movements, projection artifacts and loss of signal in areas of corneal opacities. Future improvements to motion correction and image processing may reduce these artifacts and improve image quality [53, 54] . Lastly, anterior OCTA is currently unable to perform registration and localization required for comparisons in follow-up scans -though it has been found to be potentially useful for serial scans with adjunctive software [55] .
Notwithstanding the current drawbacks of anterior OCTA, it is recognized that this technology has great potential for clinical impact. Pre-operative anterior OCTA provides information on the depth of the corneal lesion with the associated vessels when planning for fine-needle diathermy with lamellar keratoplasty [56] . Further understanding of corneal and scleral inflammatory conditions may be achieved with OCTA, which reveals vasoocclusion without blockage for extravasated dyes [57] . Anterior OCTA may be performed serially to study the extent of corneal thinning and vessel constriction with active disease, as well as new capillary formation or recanalization that may indicate response to treatment [58] . Other future applications include assessment of limbal stem cell deficiency, corneal vascularisation for risk of graft Fig. 3 Optical coherence tomography angiography (OCTA) images of the outer retina segmented layer (top row) with the projection artifact removed, depth encoded color images (middle row) and cross-sectional OCTA (bottom row) showing a type 1 neovascularization at baseline (left column), after treatment with two doses of intravitreal ranibizumab (middle column) and after an additional injection of ranibizumab and three additional injections of bevacizumab, the last given 6 months before this image was taken (right column). The type 1 NV showed a decrease in size and vessel density, with pruning of the more peripheral anastomotic vessels in response to treatment with a resultant pruned tree appearance seen 6 months after treatment (right column). In addition, there was a gradual decrease in subretinal fluid as seen on crosssectional OCTA, however, despite the achieving stability with no exudation (right column), the type 1 vessel complex still persisted rejection, evaluation of anti-angiogenic treatments, glaucoma bleb vascularity and risk of scarring and study of abnormal or new iris vessels in anterior segment ischemia or neovascular glaucoma (Fig. 5) .
Future applications of optical coherence tomography angiography In parallel with rapid advances in OCTA hardware, OCTA image analysis software is becoming increasing sophisticated. Commercially available OCTA software from multiple vendors now allows for automated measurements of both abnormal flow and non-perfusion areas (Fig. 1, supplementary  Fig. 1 ). However, further work is required to generate normative databases for comparisons and to validate the clinical utility -if any -of these measurements in prospective clinical trials and investment in the development of image databases and analysis using artificial intelligence software [59] . With the proliferation of commercial OCTA systems from multiple vendors, it will be increasingly important to understand variations in both hardware and software. For example, segmentation of the superficial and deep retinal vascular layers has been shown to differ between the various OCTA systems [60] . It will also be important to characterize the reproducibility and repeatability of measurements from the different systems in a robust manner. A number of advances in the underlying OCTA technology are also underway, including the introduction of commercially available swept source OCTA systems, and the development of variable inter-scan time acquisition protocols (VISTA) [61] . These latter protocols are of particular interest because they may allow evaluation of variable flow rates (both slow and fast) to be performed in future OCTA platforms. Improved widefield imaging OCTA imaging with retention of detail and resolution, obtained with automated montage functions will become increasingly more feasible with improvements in OCTA scanning speeds (supplementary Fig. 1 ). Finally, posterior segment OCTA is starting to be incorporated into the protocols of large, interventional clinical trials and features such as depth resolved color coded images (Fig. 3) have the potential for both qualitative and quantitative disease progression monitoring and response to treatment. As the results of these trials are reported, they will undoubtedly drive even greater adoption of posterior segment OCTA in routine clinical practice.
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